Rules Seek to Expand Diagnosis of Alzheimer’s - NYTimes.com

Rules Seek to Expand Diagnosis of Alzheimer’s - NYTimes.com

I think the key point here is not that this is really a meaningful benefit to the afflicted but to the drug companies, which can ow invest hugely in plausible but probably ineffectual remedies.